Inhibition of TGF-βRI alleviates endothelial-mesenchymal transition of mitral valve damage due to rheumatic heart disease
Yuan-Ying Liang(Guangxi Medical University), Zhiyu Zeng(Guangxi Medical University)
Cited by 0
Related Papers
Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease
|International Journal of Molecular Medicine|2019|54
Activation of activin/Smad2 and 3 signaling pathway and the potential involvement of endothelial‑mesenchymal transition in the valvular damage due to rheumatic heart disease
|Molecular Medicine Reports|2020|24
Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease
|International Journal of Molecular Medicine|2021|14
Potential Involvement of M1 Macrophage and VLA4/VCAM-1 Pathway in the Valvular Damage Due to Rheumatic Heart Disease
|Frontiers in Bioscience-Landmark|2024|5
Intervening in the S1PR1/STAT3 Signaling Pathway Attenuates Valvular Damage Due to Rheumatic Heart Disease
|Research Square (Research Square)|2020|0